Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

7TM Pharma and Ortho-McNeil team up in asthma and allergy

June 17, 2005

New treatment options for respiratory and allergic disorders disclosed in recent patents

June 15, 2005

Novel PDE3/4 inhibitors with bronchodilator and antiinflammatory properties reported

June 13, 2005

Recent Icos patents cover novel treatments for fibrotic disorders

June 10, 2005

New agents for asthma and other respiratory diseases reported in recent patent literature

June 9, 2005

Mechanisms underlying CAT-354's efficacy in asthma

June 9, 2005

SU-11248 effective in malignant pleural effusion model

June 9, 2005

New license for use of paclitaxel in treatment of emphysema

June 8, 2005

Eculizumab, an anti-C5 antibody, has therapeutic potential in severe asthma

June 7, 2005

CP-2117: Novel 2-methoxyestradiol analogue for asthma therapy

June 7, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....